Participants in the AAGL Center of Excellence for Minimally Invasive Gynecology (COEMIG) program will begin to experience benefits as soon as the medical facility and surgeon commit to pursuing the designation. Information from SRC’s other center of excellence programs indicate that surgeons, hospitals and ambulatory surgery centers can expect to gain the following benefits that reinforce the value of the COEMIG program and designation.
Professional Recognition and Distinction
Improved Safety and Efficacy
Decreased Costs and Complications
Increased Patient Awareness and Access
Network that Elevates the Specialty
Support and Communications
Regardless of how experienced surgeons are or how established departments were prior to applying to the program, pursuing and maintaining designation can be a transformative experience for the entire patient care team. SRC’s COE process challenges participants to establish a systemic culture of excellence versus simply earning a certificate. Cultivating this excellence should not end once designation is achieved; it’s an ongoing process that promotes continued improvement of a center’s minimally invasive gynecology program to help ensure that everyone involved is dedicated to caring for and meeting the needs of the patient.
By complying with the COEMIG requirements, surgeons and facilities demonstrate a commitment and ability to consistently deliver the highest level of minimally invasive gynecologic surgical care possible. Earning the COEMIG designation will signify that the facility and surgeon are among the best in the specialty, which will be an important distinction in both patient and professional settings.
COEMIG designation will also distinguish minimally invasive gynecology programs from other medical specialties. Participation in the COEMIG program will ensure that the administration and medical staff understand the benefits of minimally invasive gynecology versus traditional open surgical methods. Participants can expect designation to recognize minimally invasive gynecologists as leaders in improving care quality and raise the department’s profile within the facility, among peers and in the community.
Facilities and surgeons that participate in COEMIG are joining a safety and quality improvement program that seeks to identify and accelerate adoption of best clinical practices and cost-effective solutions. COEMIG centers will not only improve the quality of care they’re delivering to individual patients, but will also help establish the minimally invasive gynecologic specialty as a recognized leader in healthcare.
COEMIG’s central outcomes database will be used to help determine which treatment works best for which patient and under what circumstances. Information from the database should assist clinicians, patients, payors and policymakers to make informed decisions that will improve healthcare at the individual level and for the patient population as a whole.
These efforts will align with those of organizations such as the Agency for Healthcare Research and Quality (AHRQ) that are focused on comparative effectiveness research (CER). In doing so, the COEMIG outcomes database will also play an active role in accelerating adoption of minimally invasive gynecology by demonstrating improved outcomes and advancing evidence-based medicine.
Participant hospitals in other COE programs SRC administers have indicated that their involvement in the program has resulted in decreased length of stay, reduced complication rates and decreased intensive care unit (ICU) stays. These improvements result from the mandated standardization of patient care and intensive education provided to both patients and clinical staff. All of this translates into improved outcomes, cost savings and increased patient satisfaction.
COEMIG designation will help promote increased patient awareness of advanced minimally invasive gynecologic techniques. The program strives to ensure that women are aware of their minimally invasive treatment options and understand the benefits, including reduced trauma, decreased blood loss, shorter operating time, reduced risk of infection, less postoperative pain, faster healing time and minimized scarring. As patients become knowledgeable about their choices for gynecologic surgery and the benefits of less invasive techniques, more will select COEMIG-designated hospitals, ambulatory surgery centers and surgeons to perform their surgery.
Designated surgeons and facilities are able to market and differentiate themselves among gynecologic surgical care providers. The COEMIG designation will be synonymous with superior patient care, and the associated seal will be a readily identifiable symbol of a center’s achievement. Upon designation, hospitals, ambulatory surgery centers and surgeons will gain access to graphic files, key messages and marketing guidelines that their public relations and marketing staff or outside agencies can immediately leverage in their promotional efforts. Designees are encouraged to publicize their achievement through:
With the abundance of health-related topics in the mainstream news and an increased number of patient websites, consumers are seeking ways to distinguish healthcare facilities that deliver high-quality care from those that do not. Patients will increasingly recognize the importance of the COEMIG designation and use it as a guide when selecting where to have their gynecologic surgery performed.
Patients around the world are seeking access to quality healthcare from top providers – and they are increasingly willing to travel abroad to do so. Competition for these patients is intensifying, and major medical facilities and surgeons worldwide are making investments in equipment, training and the patient experience to position themselves as first-class healthcare providers.
While clinical practices can vary from country to country, the COEMIG program will help establish universal standards that will enable patients and payors to measure gynecologic surgical providers against these standards. The program will help ensure that the safest, highest quality of care is delivered to minimally invasive gynecologic patients worldwide, regardless of where they choose to have their procedure performed.
In addition to emphasizing excellence at a local level, healthcare providers will value COEMIG participation because it connects them to an elite group who are similarly dedicated to delivering safe, cost-effective, high-quality patient care. Significant participation in COEMIG and its central outcomes database is not only essential to accelerating adoption of minimally invasive gynecology, but also integral to strengthening healthcare advocacy efforts on behalf of the specialty that address quality improvement, reimbursement issues, pay-for-performance and more.
Integral to the program’s success will be data collection through SRC’s proprietary central outcomes database. The database will ensure program compliance and support outcomes-based medicine that will accelerate adoption of minimally invasive gynecology.
Through the outcomes database, COEMIG surgeons will gain real-time access to individual patient information that supports clinical decisions. Providers can also obtain meaningful data through numerous daily reports that are based on information from the surgeon’s individual practice. National summary reports enable participants to compare their individual outcomes to aggregate data and assess their approach to care. While information from the outcomes database will be readily available to surgeons participating in the program, surgeon-specific data will not be disclosed without the surgeon’s consent.
Ultimately, the database will be most beneficial to minimally invasive gynecologic surgery patients, as providers will use its data to determine the most effective procedures and most appropriate care for each patient. Over time, aggregate data could prove pivotal in advocacy efforts for the specialty in each country.
Surgeons and facilities are encouraged to schedule a one-on-one consultation with a COEMIG support team member. During this phone call, a representative will learn about your minimally invasive gynecology program, explain the designation process and answer any questions you may have.
SRC Support representatives are available Monday-Friday from 8:30 am-5:30 pm Eastern time at 1.919.981.4460 or via email at firstname.lastname@example.org (coemigsupport null@null surgicalreview NULL.org).
Participants will also receive regular communications containing information on program developments, benefits and news highlights.